Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance (RSV)
The Effect of Resveratrol in Older Adults With Impaired Glucose Tolerance: a Double-Blind Crossover Study
Sponsor: Albert Einstein College of Medicine
This NA trial investigates Impaired Glucose Tolerance and is currently completed. Albert Einstein College of Medicine leads this study, which shows 14 recorded versions since 2011 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
14 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
-
Sep 2024 — Sep 2025 [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Nov 2022 — Jul 2024 [monthly]
Completed NA
-
Jan 2022 — Nov 2022 [monthly]
Completed NA
▶ Show 9 earlier versions
-
Nov 2021 — Jan 2022 [monthly]
Completed NA
-
Sep 2021 — Nov 2021 [monthly]
Completed NA
-
May 2021 — Sep 2021 [monthly]
Completed NA
-
Jan 2021 — May 2021 [monthly]
Completed NA
-
Sep 2020 — Jan 2021 [monthly]
Completed NA
Status: Unknown Status → Completed
-
Feb 2019 — Sep 2020 [monthly]
Unknown Status NA
-
Jun 2018 — Feb 2019 [monthly]
Unknown Status NA
-
Feb 2017 — Jun 2018 [monthly]
Unknown Status NA
-
Jan 2017 — Feb 2017 [monthly]
Unknown Status NA
First recorded
Apr 2011
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Albert Einstein College of Medicine
- American Diabetes Association
For direct contact, visit the study record on ClinicalTrials.gov .